China seeks to expand API trade with India

04/29/2013 | PharmaBiz.com (India)

India has become China's top market for active pharmaceutical ingredients, now estimated at almost $2 billion annually, or almost 15% of its API exports, and many Chinese pharma companies are eager to expand that trade. "China should adopt the high standards of quality and also look to making strides in the generic industry here," said Shi Shengyi, speaking for the China National Pharmaceutical Group Corp., Sinopharm.

View Full Article in:

PharmaBiz.com (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN